<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31251408</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>Identification and characterization of permissive cells to dengue virus infection in human hematopoietic stem and progenitor cells.</ArticleTitle><Pagination><StartPage>2938</StartPage><EndPage>2951</EndPage><MedlinePgn>2938-2951</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.15416</ELocationID><Abstract><AbstractText Label="BACKGROUND">Dengue virus (DENV) is a significant threat to public health in tropical and subtropical regions, where the frequency of human migration is increasing. Transmission of DENV from donors to recipients after hematopoietic stem cell transplantation has been steadily described. However, the underlying mechanisms remain unclear.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS">Freshly isolated bone marrow (BM) was subjected to DENV infection, followed by multicolor fluorescence-activated cell sorting (FACS) analysis. Virus in supernatants was collected and analyzed by plaque assay.</AbstractText><AbstractText Label="RESULTS">DENV-1 to DENV-4 could effectively infect freshly obtained BM and produced infectious virus. DENV infection did not change the quantitative population of hematopoietic stem and progenitor cells (HSPCs), megakaryocytic progenitor cells (MkPs) and megakaryocytes. Additionally, DENV antigen, nonstructural protein 1, was enriched in HSPCs and MkPs of DENV infected marrow cells. CD34+, CD133+, or CD61+ cells sorted out from BM were not only the major contributing targets facilitating the DENV infection directly but also facilitated the spread of DENV into other cells when cocultured.</AbstractText><AbstractText Label="CONCLUSION">Results suggest that DENV can efficiently infect HSPCs, which might jeopardize the recipients if DENV-infected cells were subsequently used. We therefore raise the need for DENV screening for both the donors and recipients of hematopoietic stem cell transplantation, especially for donors exposed to endemic areas, to mitigate DENV infection in immunocompromised recipients.</AbstractText><CopyrightInformation>&#xa9; 2019 AABB.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Alan Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, Purdue University, West Lafayette, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzu-Chuan</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Mei-Ling</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Sia Seng</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tsai-Yun</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Meed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chien</LastName><ForeName>Yu-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Departement of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ya-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Guey Chuen</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0001-7510-4486</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001854" MajorTopicYN="N">Bone Marrow Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005312" MajorTopicYN="N">Fetal Blood</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018380" MajorTopicYN="N">Hematopoietic Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006412" MajorTopicYN="N">Hematopoietic Stem Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016130" MajorTopicYN="N">Immunophenotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008533" MajorTopicYN="N">Megakaryocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023461" MajorTopicYN="N">Myeloid Progenitor Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="Y">Viral Plaque Assay</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31251408</ArticleId><ArticleId IdType="doi">10.1111/trf.15416</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013;496:504-7.</Citation></Reference><Reference><Citation>Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010;8:S7-16.</Citation></Reference><Reference><Citation>Watterson D, Modhiran N, Young PR. The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design. Antiviral Res 2016;130:7-18.</Citation></Reference><Reference><Citation>Puerta-Guardo H, Glasner DR, Harris E. Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. PLoS Pathog 2016;12:e1005738.</Citation></Reference><Reference><Citation>Muller DA, Young PR. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res 2013;98:192-208.</Citation></Reference><Reference><Citation>Chen HR, Chuang YC, Lin YS, et al. Dengue virus nonstructural protein 1 induces vascular leakage through macrophage migration inhibitory factor and autophagy. PLoS Negl Trop Dis 2016;10:e0004828.</Citation></Reference><Reference><Citation>WHO. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded edition. New Delhi, India: World Health Organization; 2011. p. 60.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Locally acquired dengue--Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep 2010;59:577-81.</Citation></Reference><Reference><Citation>Radke EG, Gregory CJ, Kintziger KW, et al. Dengue outbreak in Key West, Florida, USA, 2009. Emerg Infect Dis 2012;18:135-7.</Citation></Reference><Reference><Citation>Thomas DL, Santiago GA, Abeyta R, et al. Reemergence of dengue in Southern Texas, 2013. Emerg Infect Dis 2016;22:1002-7.</Citation></Reference><Reference><Citation>WHO. Dengue guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization; 2009.</Citation></Reference><Reference><Citation>Tambyah PA, Koay ES, Poon ML, et al. Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008;359:1526-7.</Citation></Reference><Reference><Citation>Anez G, Heisey DA, Chancey C, et al. Distribution of dengue virus types 1 and 4 in blood components from infected blood donors from Puerto Rico. PLoS Negl Trop Dis 2016;10:e0004445.</Citation></Reference><Reference><Citation>Rigau-Perez JG, Vorndam AV, Clark GG. The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am J Trop Med Hyg 2001;64:67-74.</Citation></Reference><Reference><Citation>Punzel M, Korukluoglu G, Caglayik DY, et al. Dengue virus transmission by blood stem cell donor after travel to Sri Lanka; Germany, 2013. Emerg Infect Dis 2014;20:1366-9.</Citation></Reference><Reference><Citation>Visuthranukul J, Bunworasate U, Lawasut P, et al. Dengue hemorrhagic fever in a peripheral blood stem cell transplant recipient: the first case report. Infect Dis Rep 2009;1:e3.</Citation></Reference><Reference><Citation>Barroso KSN, Kaufman J, Brunetta DM, et al. Dengue encephalitis in allogenic hematopoietic stem cell transplantation recipient. Bone Marrow Transplant 2017;52:1455-6.</Citation></Reference><Reference><Citation>de Souza Pereira BB, Darrigo Junior LG, de Mello Costa TC, et al. Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Transpl Infect Dis 2017;19:e12721.</Citation></Reference><Reference><Citation>Costa SD, da Silva GB Jr, Jacinto CN, et al. Dengue fever among renal transplant recipients: a series of 10 cases in a tropical country. Am J Trop Med Hyg 2015;93:394-6.</Citation></Reference><Reference><Citation>Nanmoku K, Yamamoto T, Tsujita M, et al. Virus-associated hemophagocytic syndrome in renal transplant recipients: report of 2 cases from a single center. Case Rep Hematol 2015;2015:876301.</Citation></Reference><Reference><Citation>Saigal S, Choudhary NS, Saraf N, et al. Transmission of dengue virus from a donor to a recipient after living donor liver transplantation. Liver Transpl 2013;19:1413-4.</Citation></Reference><Reference><Citation>Nasim A, Anis S, Baqi S, et al. Clinical presentation and outcome of dengue viral infection in live-related renal transplant recipients in Karachi, Pakistan. Transpl Infect Dis 2013;15:516-25.</Citation></Reference><Reference><Citation>Lee C, Jang EJ, Kwon D, et al. Laboratory-acquired dengue virus infection by needlestick injury: a case report, South Korea, 2014. Ann Occup Environ Med 2016;28:16.</Citation></Reference><Reference><Citation>Ohnishi K. Needle-stick dengue virus infection in a health-care worker at a Japanese hospital. J Occup Health 2015;57:482-3.</Citation></Reference><Reference><Citation>Morgan C, Paraskevopoulou SM, Ashley EA, et al. Nosocomial transmission of dengue fever via needlestick. An occupational risk. Travel Med Infect Dis 2015;13:271-3.</Citation></Reference><Reference><Citation>Yin X, Zhong X, Pan S. Vertical transmission of dengue infection: the first putative case reported in China. Rev Inst Med Trop Sao Paulo 2016;58:90.</Citation></Reference><Reference><Citation>Arragain L, Dupont-Rouzeyrol M, O'Connor O, et al. Vertical transmission of dengue virus in the peripartum period and viral kinetics in newborns and breast milk: new data. J Pediatric Infect Dis Soc 2017;6:324-31.</Citation></Reference><Reference><Citation>Sinhabahu VP, Sathananthan R, Malavige GN. Perinatal transmission of dengue: a case report. BMC Res Notes 2014;7:795.</Citation></Reference><Reference><Citation>Mann TZ, Haddad LB, Williams TR, et al. Breast milk transmission of flaviviruses in the context of Zika virus: a systematic review. Paediatr Perinat Epidemiol 2018;32:358-68.</Citation></Reference><Reference><Citation>Sabino EC, Loureiro P, Lopes ME, et al. Transfusion-transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis 2016;213:694-702.</Citation></Reference><Reference><Citation>Chien YW, Shu YC, Chuang KT, et al. High estimated prevalence of asymptomatic dengue viremia in blood donors during a dengue epidemic in southern Taiwan, 2015. Transfusion 2017;57:2649-56.</Citation></Reference><Reference><Citation>Linnen JM, Vinelli E, Sabino EC, et al. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 2008;48:1355-62.</Citation></Reference><Reference><Citation>Stramer SL, Linnen JM, Carrick JM, et al. Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012;52:1657-66.</Citation></Reference><Reference><Citation>Darrigo LG Jr, de Sant'Anna Carvalho AM, Machado CM. Chikungunya, Dengue, and Zika in immunocompromised hosts. Curr Infect Dis Rep 2018;20:5.</Citation></Reference><Reference><Citation>Garcia JH, Rocha TD, Viana CF, et al. Dengue shock syndrome in a liver transplant recipient. Transplantation 2006;82:850-1.</Citation></Reference><Reference><Citation>Tsai J-J, Liu L-T, Chang K, et al. The importance of hematopoietic progenitor cells in dengue. Ther Adv Hematol 2012;3:59-71.</Citation></Reference><Reference><Citation>Nakao S, Lai CJ, Young NS. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood 1989;74:1235-40.</Citation></Reference><Reference><Citation>Pham AM, Langlois RA, TenOever BR. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog 2012;8:e1002465.</Citation></Reference><Reference><Citation>Hsu AY, Wu SR, Tsai JJ, et al. Infectious dengue vesicles derived from CD61+ cells in acute patient plasma exhibited a diaphanous appearance. Sci Rep 2015;5:17990.</Citation></Reference><Reference><Citation>Lang J, Vera D, Cheng Y, et al. Modeling dengue virus-hepatic cell interactions using human pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Reports 2016;7:341-54.</Citation></Reference><Reference><Citation>Notta F, Zandi S, Takayama N, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science 2016;351:aab2116.</Citation></Reference><Reference><Citation>Mueller MM, Bialleck H, Bomke B, et al. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study. Vox Sang 2013;104:46-54.</Citation></Reference><Reference><Citation>Walasek MA, van Os R, de Haan G. Hematopoietic stem cell expansion: challenges and opportunities. Ann N Y Acad Sci 2012;1266:138-50.</Citation></Reference><Reference><Citation>Noisakran S, Onlamoon N, Hsiao HM, et al. Infection of bone marrow cells by dengue virus in vivo. Exp Hematol 2012;40:250-9 e4.</Citation></Reference><Reference><Citation>Clark KB, Noisakran S, Onlamoon N, et al. Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow. PLoS One 2012;7:e52902.</Citation></Reference><Reference><Citation>Clark KB, Hsiao HM, Bassit L, et al. Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells. Virology 2016;493:162-72.</Citation></Reference><Reference><Citation>Audia S, Mahevas M, Samson M, et al. Pathogenesis of immune thrombocytopenia. Autoimmun Rev 2017;16:620-32.</Citation></Reference><Reference><Citation>Khodadi E, Asnafi AA, Shahrabi S, et al. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis. Ann Hematol 2016;95:1765-76.</Citation></Reference><Reference><Citation>Scott RM, Nisalak A, Cheamudon U, et al. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 1980;141:1-6.</Citation></Reference><Reference><Citation>Noisakran S, Onlamoon N, Songprakhon P, et al. Cells in Dengue Virus Infection In Vivo. Adv Virol 2010;2010:1-15.</Citation></Reference><Reference><Citation>Jessie K, Fong MY, Devi S, et al. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004;189:1411-8.</Citation></Reference><Reference><Citation>Noisakran S, Onlamoon N, Pattanapanyasat K, et al. Role of CD61(+) cells in thrombocytopenia of dengue patients. Int J Hematol 2012;96:600-10.</Citation></Reference><Reference><Citation>Bente DA, Melkus MW, Garcia JV, et al. Dengue fever in humanized NOD/SCID mice. J Virol 2005;79:13797-9.</Citation></Reference><Reference><Citation>Halstead SB, O'Rourke EJ, Allison AC. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med 1977;146:218-29.</Citation></Reference><Reference><Citation>Young NS. Flaviviruses and bone marrow failure. JAMA 1990;263:3065-8.</Citation></Reference><Reference><Citation>Kho LK, Wulur H, Himawan T. Blood and bone marrow changes in dengue haemorrhagic fever. Paediatr Indones 1972;12:31-9.</Citation></Reference><Reference><Citation>Nisalak A, Halstead SB, Singharaj P, et al. Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease. Yale J Biol Med 1970;42:293-310.</Citation></Reference><Reference><Citation>Chan YC, Lim KA, Ho BC. Recent epidemics of hemorrhagic fever in Singapore. Jap J Med Sci Biol 1967;20:81-8.</Citation></Reference><Reference><Citation>Au WY, Ma ES, Kwong YL. Acute myeloid leukemia precipitated by dengue virus infection in a patient with hemoglobin H disease. Haematologica 2001;86:e17.</Citation></Reference><Reference><Citation>Srichaikul T, Punyagupta S, Kanchanapoom T, et al. Hemophagocytic syndrome in Dengue hemorrhagic fever with severe multiorgan complications. J Med Assoc Thai 2008;91:104-9.</Citation></Reference><Reference><Citation>Perng GC. Role of bone marrow in pathogenesis of viral infections. J Bone Marrow Res 2013;1:102.</Citation></Reference><Reference><Citation>Swinkels M, Rijkers M, Voorberg J, et al. Emerging concepts in immune thrombocytopenia. Front Immunol 2018;9:880.</Citation></Reference><Reference><Citation>Attatippaholkun N, Kosaisawe N, Y UP, et al. Selective tropism of Dengue virus for human glycoprotein Ib. Sci Rep 2018;8:2688.</Citation></Reference><Reference><Citation>Machado CM, Pereira BBS, Felix AC, et al. Zika and chikungunya virus infections in hematopoietic stem cell transplant recipients and oncohematological patients. Blood Adv 2017;1:624-7.</Citation></Reference><Reference><Citation>Petersen LR, Busch MP. Transfusion-transmitted arboviruses. Vox Sang 2010;98:495-503.</Citation></Reference><Reference><Citation>Teo D, Ng LC, Lam S. Is dengue a threat to the blood supply? Transfus Med 2009;19:66-77.</Citation></Reference><Reference><Citation>Wilder-Smith A, Chen LH, Massad E, et al. Threat of dengue to blood safety in dengue-endemic countries. Emerg Infect Dis 2009;15:8-11.</Citation></Reference><Reference><Citation>Waggoner JJ, Soda EA, Deresinski S. Rare and emerging viral infections in transplant recipients. Clin Infect Dis 2013;57:1182-8.</Citation></Reference><Reference><Citation>Dejnirattisai W, Webb AI, Chan V, et al. Lectin switching during dengue virus infection. J Infect Dis 2011;203:1775-83.</Citation></Reference><Reference><Citation>Conway MJ, Watson AM, Colpitts TM, et al. Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host. J Virol 2014;88:164-75.</Citation></Reference><Reference><Citation>Surasombatpattana P, Ekchariyawat P, Hamel R, et al. Aedes aegypti saliva contains a prominent 34-kDa protein that strongly enhances dengue virus replication in human keratinocytes. J Invest Dermatol 2014;134:281-4.</Citation></Reference><Reference><Citation>Guilarde AO, Turchi MD, Siqueira JB Jr, et al. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis 2008;197:817-24.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>